iBio, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 14 →Insiders3 insiders bought $98,109 in 4 open-market buys. No sales.→HoldersAffinity Asset 7.2%Cormorant 6.4%Silverarc 6.3%→Financing →PeersClosest companies: CTMX, IPSC, HCWB→
From the filings
Figures
- Revenue
- $100,000last 12 months
- Net income
- −$32.8Mlast 12 months
- Operating cash flow
- −$23.2Mlast 12 months
- Cash and equivalents
- $56.4Mat the last balance sheet
- Shares outstanding
- 55.7M shareson issue